{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:59:48Z","timestamp":1790251188261,"version":"4.1.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,7,29]],"date-time":"2012-07-29T00:00:00Z","timestamp":1343520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00405-012-2126-0","type":"journal-article","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T13:36:12Z","timestamp":1343482572000},"page":"793-804","source":"Crossref","is-referenced-by-count":32,"title":["Perspectives of pharmacological treatment in otosclerosis"],"prefix":"10.1007","volume":"270","author":[{"given":"Bal\u00e1zs","family":"Liktor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szekanecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s J\u00f3zsef","family":"Batta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Sziklai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Karosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,29]]},"reference":[{"issue":"44","key":"2126_CR1","first-page":"2435","volume":"140","author":"Z Szekanecz","year":"1999","unstructured":"Szekanecz Z, Szekanecz E, Morvai K, Racz T, Szegedi G, Sziklai I (1999) Current aspects of the pathogenesis and clinical characteristics of otosclerosis: possibilities of drug therapy. Orv Hetil 140(44):2435\u20132440","journal-title":"Orv Hetil"},{"issue":"2","key":"2126_CR2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.autrev.2009.03.009","volume":"9","author":"T Karosi","year":"2009","unstructured":"Karosi T, Szekanecz Z, Sziklai I (2009) Otosclerosis: an autoimmune disease? Autoimmun Rev 9(2):95\u2013101","journal-title":"Autoimmun Rev"},{"key":"2126_CR3","doi-asserted-by":"crossref","unstructured":"Niedermeyer HP, Arnold W, Neubert WJ, Sedlmeier R (2000) Persistent measles virus infection as a possible cause of otosclerosis: state of the art. Ear Nose Throat J 79(8):552\u2013554 (556, 558 passim)","DOI":"10.1177\/014556130007900807"},{"issue":"3","key":"2126_CR4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/01.mlg.0000204142.80263.2b","volume":"116","author":"T Karosi","year":"2006","unstructured":"Karosi T, Konya J, Petko M, Szabo LZ, Pytel J, Jori J et al (2006) Antimeasles immunoglobulin g for serologic diagnosis of otosclerotic hearing loss. Laryngoscope 116(3):488\u2013493","journal-title":"Laryngoscope"},{"issue":"11","key":"2126_CR5","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s00405-009-0967-y","volume":"266","author":"I Sziklai","year":"2009","unstructured":"Sziklai I, Batta TJ, Karosi T (2009) Otosclerosis: an organ-specific inflammatory disease with sensorineural hearing loss. Eur Arch Otorhinolaryngol 266(11):1711\u20131718","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"11","key":"2126_CR6","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1097\/01.mlg.0000178325.48942.f1","volume":"115","author":"T Karosi","year":"2005","unstructured":"Karosi T, Konya J, Petko M, Szabo LZ, Pytel J, Jori J et al (2005) Two subgroups of stapes fixation: otosclerosis and pseudo-otosclerosis. Laryngoscope 115(11):1968\u20131973","journal-title":"Laryngoscope"},{"issue":"2","key":"2126_CR7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1742-1241.2009.02046.x","volume":"64","author":"S Uppal","year":"2010","unstructured":"Uppal S, Bajaj Y, Coatesworth AP (2010) Otosclerosis 2: the medical management of otosclerosis. Int J Clin Pract 64(2):256\u2013265","journal-title":"Int J Clin Pract"},{"issue":"10","key":"2126_CR8","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1742-1241.2009.02045.x","volume":"63","author":"S Uppal","year":"2009","unstructured":"Uppal S, Bajaj Y, Rustom I, Coatesworth AP (2009) Otosclerosis 1: the aetiopathogenesis of otosclerosis. Int J Clin Pract 63(10):1526\u20131530","journal-title":"Int J Clin Pract"},{"issue":"4","key":"2126_CR9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri2062","volume":"7","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi H (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7(4):292\u2013304","journal-title":"Nat Rev Immunol"},{"issue":"5484","key":"2126_CR10","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","volume":"289","author":"SL Teitelbaum","year":"2000","unstructured":"Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289(5484):1504\u20131508","journal-title":"Science"},{"issue":"1","key":"2126_CR11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/01.mlg.0000150702.28451.35","volume":"115","author":"AF Zehnder","year":"2005","unstructured":"Zehnder AF, Kristiansen AG, Adams JC, Merchant SN, McKenna MJ (2005) Osteoprotegerin in the inner ear may inhibit bone remodeling in the otic capsule. Laryngoscope 115(1):172\u2013177","journal-title":"Laryngoscope"},{"issue":"8","key":"2126_CR12","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/01.mlg.0000225928.35838.e5","volume":"116","author":"T Karosi","year":"2006","unstructured":"Karosi T, Jokay I, Konya J, Szabo LZ, Pytel J, Jori J et al (2006) Detection of osteoprotegerin and TNF-alpha mRNA in ankylotic Stapes footplates in connection with measles virus positivity. Laryngoscope 116(8):1427\u20131433","journal-title":"Laryngoscope"},{"issue":"2","key":"2126_CR13","first-page":"92","volume":"14","author":"K Brookler","year":"2008","unstructured":"Brookler K (2008) Medical treatment of otosclerosis: rationale for use of bisphosphonates. Int Tinnitus J 14(2):92\u201396","journal-title":"Int Tinnitus J"},{"issue":"6","key":"2126_CR14","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/01.mao.0000169304.72519.d2","volume":"26","author":"T Karosi","year":"2005","unstructured":"Karosi T, Konya J, Petko M, Sziklai I (2005) Histologic otosclerosis is associated with the presence of measles virus in the stapes footplate. Otol Neurotol 26(6):1128\u20131133","journal-title":"Otol Neurotol"},{"issue":"7","key":"2126_CR15","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/01.MLG.0000165462.35495.DF","volume":"115","author":"T Karosi","year":"2005","unstructured":"Karosi T, Konya J, Szabo LZ, Pytel J, Jori J, Szalmas A et al (2005) Codetection of measles virus and tumor necrosis factor-alpha mRNA in otosclerotic stapes footplates. Laryngoscope 115(7):1291\u20131297","journal-title":"Laryngoscope"},{"issue":"3","key":"2126_CR16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00405-010-1404-y","volume":"268","author":"T Karosi","year":"2011","unstructured":"Karosi T, Csomor P, Szalmas A, Konya J, Petko M, Sziklai I (2011) Osteoprotegerin expression and sensitivity in otosclerosis with different histological activity. Eur Arch Otorhinolaryngol 268(3):357\u2013365","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"6","key":"2126_CR17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/MAO.0b013e3181e3dedf","volume":"31","author":"P Csomor","year":"2010","unstructured":"Csomor P, Sziklai I, Liktor B, Szabo L, Pytel J, Jori J et al (2010) Otosclerosis: disturbed balance between cell survival and apoptosis. Otol Neurotol 31(6):867\u2013874","journal-title":"Otol Neurotol"},{"issue":"8","key":"2126_CR18","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/MAO.0b013e3181be6af4","volume":"30","author":"P Csomor","year":"2009","unstructured":"Csomor P, Sziklai I, Karosi T (2009) TNF-alpha receptor expression correlates with histologic activity of otosclerosis. Otol Neurotol 30(8):1131\u20131137","journal-title":"Otol Neurotol"},{"issue":"3","key":"2126_CR19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00129492-200205000-00015","volume":"23","author":"JC Adams","year":"2002","unstructured":"Adams JC (2002) Clinical implications of inflammatory cytokines in the cochlea: a technical note. Otol Neurotol 23(3):316\u2013322","journal-title":"Otol Neurotol"},{"issue":"5\u20136","key":"2126_CR20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3109\/00016488809119518","volume":"105","author":"O Ribari","year":"1988","unstructured":"Ribari O, Sziklai I (1988) Cathepsin D activity in otosclerotic bone and perilymph. Acta Otolaryngol 105(5\u20136):549\u2013552","journal-title":"Acta Otolaryngol"},{"issue":"6","key":"2126_CR21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000275953","volume":"49","author":"O Ribari","year":"1987","unstructured":"Ribari O, Sziklai I, Kiss GJ (1987) Proteolytic enzymes in otosclerosis. Significance of proteolytic enzymes in otosclerotic bone remodelling. ORL J Otorhinolaryngol Relat Spec 49(6):282\u2013286","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"2","key":"2126_CR22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00454303","volume":"238","author":"O Ribari","year":"1983","unstructured":"Ribari O, Sziklai I, Kiss JG, Sohar I (1983) Cathepsin-B activity in otosclerosis. Arch Otorhinolaryngol 238(2):123\u2013125","journal-title":"Arch Otorhinolaryngol"},{"issue":"9","key":"2126_CR23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/ncprheum0881","volume":"4","author":"G Schett","year":"2008","unstructured":"Schett G, Zwerina J, David JP (2008) The role of Wnt proteins in arthritis. Nat Clin Pract Rheumatol 4(9):473\u2013480","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"2","key":"2126_CR24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D et al (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13(2):156\u2013163","journal-title":"Nat Med"},{"issue":"4","key":"2126_CR25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10162-011-0267-2","volume":"12","author":"R Chai","year":"2011","unstructured":"Chai R, Xia A, Wang T, Jan TA, Hayashi T, Bermingham-McDonogh O et al (2011) Dynamic expression of Lgr5, a Wnt target gene, in the developing and mature mouse cochlea. J Assoc Res Otolaryngol 12(4):455\u2013469","journal-title":"J Assoc Res Otolaryngol"},{"issue":"6","key":"2126_CR26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/cne.22169","volume":"517","author":"UJ Sienknecht","year":"2009","unstructured":"Sienknecht UJ, Fekete DM (2009) Mapping of Wnt, frizzled, and Wnt inhibitor gene expression domains in the avian otic primordium. J Comp Neurol 517(6):751\u2013764","journal-title":"J Comp Neurol"},{"issue":"6","key":"2126_CR27","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1371\/journal.pone.0000525","volume":"2","author":"RD Hawkins","year":"2007","unstructured":"Hawkins RD, Bashiardes S, Powder KE, Sajan SA, Bhonagiri V, Alvarado DM et al (2007) Large scale gene expression profiles of regenerating inner ear sensory epithelia. PLoS One 2(6):e525","journal-title":"PLoS One"},{"issue":"1","key":"2126_CR28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/PL00008243","volume":"202","author":"M Matsuda","year":"2000","unstructured":"Matsuda M, Keino H (2000) Roles of beta-catenin in inner ear development in rat embryos. Anat Embryol (Berl) 202(1):39\u201348","journal-title":"Anat Embryol (Berl)"},{"key":"2126_CR29","first-page":"61","volume":"65","author":"H Hamersma","year":"2007","unstructured":"Hamersma H, Hofmeyr L (2007) Too much bone: the middle ear in sclerosing bone dysplasias. Adv Otorhinolaryngol 65:61\u201367","journal-title":"Adv Otorhinolaryngol"},{"key":"2126_CR30","unstructured":"Kanaan RA, Kanaan LA (2006) Transforming growth factor beta1, bone connection. Med Sci Monit 12(8):RA164\u2013RA169"},{"key":"2126_CR31","doi-asserted-by":"crossref","unstructured":"Csomor P, Liktor B, Szekanecz Z, Sziklai I, Karosi T (2012) Expression of bone morphogenetic protein 2, 4, 5, and 7 correlates with histological activity of otosclerotic foci. Acta Otolaryngol (Epub ahead of print)","DOI":"10.3109\/00016489.2011.653669"},{"issue":"4","key":"2126_CR32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1359\/jbmr.071112","volume":"23","author":"I Schrauwen","year":"2008","unstructured":"Schrauwen I, Thys M, Vanderstraeten K, Fransen E, Dieltjens N, Huyghe JR et al (2008) Association of bone morphogenetic proteins with otosclerosis. J Bone Miner Res 23(4):507\u2013516","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2126_CR33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1742-1241.2009.02047.x","volume":"64","author":"Y Bajaj","year":"2010","unstructured":"Bajaj Y, Uppal S, Bhatti I, Coatesworth AP (2010) Otosclerosis 3: the surgical management of otosclerosis. Int J Clin Pract 64(4):505\u2013510","journal-title":"Int J Clin Pract"},{"issue":"6","key":"2126_CR34","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/00129492-200311000-00005","volume":"24","author":"AB Grayeli","year":"2003","unstructured":"Grayeli AB, Escoubet B, Bichara M, Julien N, Silve C, Friedlander G et al (2003) Increased activity of the diastrophic dysplasia sulfate transporter in otosclerosis and its inhibition by sodium fluoride. Otol Neurotol 24(6):854\u2013862","journal-title":"Otol Neurotol"},{"issue":"9","key":"2126_CR35","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/01.mlg.0000231733.02481.59","volume":"116","author":"Y Imauchi","year":"2006","unstructured":"Imauchi Y, Lombes M, Laine P, Sterkers O, Ferrary E, Grayeli AB (2006) Glucocorticoids inhibit diastrophic dysplasia sulfate transporter activity in otosclerosis by interleukin-6. Laryngoscope 116(9):1647\u20131650","journal-title":"Laryngoscope"},{"issue":"1","key":"2126_CR36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1017\/S0022215100136345","volume":"111","author":"E Vartiainen","year":"1997","unstructured":"Vartiainen E, Vartiainen T (1997) Effect of drinking water fluoridation on the prevalence of otosclerosis. J Laryngol Otol 111(1):20\u201322","journal-title":"J Laryngol Otol"},{"issue":"5","key":"2126_CR37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3109\/00016489609137918","volume":"116","author":"E Vartiainen","year":"1996","unstructured":"Vartiainen E, Vartiainen J (1996) The effect of drinking water fluoridation on the natural course of hearing in patients with otosclerosis. Acta Otolaryngol 116(5):747\u2013750","journal-title":"Acta Otolaryngol"},{"issue":"1","key":"2126_CR38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1365-2273.1997.00853.x","volume":"22","author":"E Vartiainen","year":"1997","unstructured":"Vartiainen E, Vartiainen J (1997) The influence of fluoridation of drinking water on the long-term hearing results of stapedectomy. Clin Otolaryngol Allied Sci 22(1):34\u201336","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"5","key":"2126_CR39","first-page":"482","volume":"14","author":"JR Causse","year":"1993","unstructured":"Causse JR, Causse JB, Uriel J, Berges J, Shambaugh GE Jr, Bretlau P (1993) Sodium fluoride therapy. Am J Otol 14(5):482\u2013490","journal-title":"Am J Otol"},{"issue":"3","key":"2126_CR40","first-page":"195","volume":"12","author":"V Colletti","year":"1991","unstructured":"Colletti V, Fiorino FG (1991) Effect of sodium fluoride on early stages of otosclerosis. Am J Otol 12(3):195\u2013198","journal-title":"Am J Otol"},{"key":"2126_CR41","doi-asserted-by":"crossref","unstructured":"Bretlau P, Causse J, Causse JB, Hansen HJ, Johnsen NJ, Salomon G (1985) Otospongiosis and sodium fluoride. A blind experimental and clinical evaluation of the effect of sodium fluoride treatment in patients with otospongiosis. Ann Otol Rhinol Laryngol 94(2 Pt 1):103\u2013107","DOI":"10.1177\/000348948509400201"},{"issue":"1","key":"2126_CR42","first-page":"20","volume":"10","author":"P Bretlau","year":"1989","unstructured":"Bretlau P, Salomon G, Johnsen NJ (1989) Otospongiosis and sodium fluoride. A clinical double-blind, placebo-controlled study on sodium fluoride treatment in otospongiosis. Am J Otol 10(1):20\u201322","journal-title":"Am J Otol"},{"key":"2126_CR43","doi-asserted-by":"crossref","unstructured":"Kennel KA, Drake MT (2009) Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin Proc 84(7):632\u2013637 (quiz 638)","DOI":"10.4065\/84.7.632"},{"issue":"2","key":"2126_CR44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.14310\/horm.2002.1226","volume":"8","author":"PD Papapetrou","year":"2009","unstructured":"Papapetrou PD (2009) Bisphosphonate-associated adverse events. Hormones (Athens) 8(2):96\u2013110","journal-title":"Hormones (Athens)"},{"issue":"1","key":"2126_CR45","first-page":"89","volume":"6","author":"JJ Stutzmann","year":"1985","unstructured":"Stutzmann JJ, Petrovic AG (1985) Diphosphonates for otospongiosis. Am J Otol 6(1):89\u201395","journal-title":"Am J Otol"},{"issue":"3 Pt 1","key":"2126_CR46","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/019459989310900312","volume":"109","author":"DW Kennedy","year":"1993","unstructured":"Kennedy DW, Hoffer ME, Holliday M (1993) The effects of etidronate disodium on progressive hearing loss from otosclerosis. Otolaryngol Head Neck Surg 109(3 Pt 1):461\u2013467","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"872","key":"2126_CR47","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/pgmj.74.872.363","volume":"74","author":"S Yasil","year":"1998","unstructured":"Yasil S, Comlekci A, Guneri A (1998) Further hearing loss during osteoporosis treatment with etidronate. Postgrad Med J 74(872):363\u2013364","journal-title":"Postgrad Med J"},{"issue":"4","key":"2126_CR48","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF00173660","volume":"248","author":"LJ Boumans","year":"1991","unstructured":"Boumans LJ, Poublon RM (1991) The detrimental effect of aminohydroxypropylidene bisphosphonate (APD) in otospongiosis. Eur Arch Otorhinolaryngol 248(4):218\u2013221","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"2126_CR49","first-page":"10","volume":"4","author":"KA Head","year":"1999","unstructured":"Head KA (1999) Ipriflavone: an important bone-building isoflavone. Altern Med Rev 4(1):10\u201322","journal-title":"Altern Med Rev"},{"issue":"2","key":"2126_CR50","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/00016489509139313","volume":"115","author":"I Sziklai","year":"1995","unstructured":"Sziklai I, Ribari O (1995) Flavonoids alter bone-remodelling in auditory ossicle organ cultures. Acta Otolaryngol 115(2):296\u2013299","journal-title":"Acta Otolaryngol"},{"issue":"5\u20136","key":"2126_CR51","first-page":"657","volume":"103","author":"O Ribari","year":"1987","unstructured":"Ribari O, Sziklai I (1987) Effect of flavonoid on PGE2-induced alterations in percentage collagen synthesis in ossicle organ cultures. Acta Otolaryngol 103(5\u20136):657\u2013660","journal-title":"Acta Otolaryngol"},{"issue":"3","key":"2126_CR52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00298613","volume":"56","author":"R Civitelli","year":"1995","unstructured":"Civitelli R, Abbasi-Jarhomi SH, Halstead LR, Dimarogonas A (1995) Ipriflavone improves bone density and biomechanical properties of adult male rat bones. Calcif Tissue Int 56(3):215\u2013219","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"2126_CR53","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/BF00369217","volume":"59","author":"C Ghezzo","year":"1996","unstructured":"Ghezzo C, Civitelli R, Cadel S, Borelli G, Maiorino M, Bufalino L et al (1996) Ipriflavone does not alter bone apatite crystal structure in adult male rats. Calcif Tissue Int 59(6):496\u2013499","journal-title":"Calcif Tissue Int"},{"issue":"1\u20132","key":"2126_CR54","first-page":"101","volume":"33","author":"I Sziklai","year":"1992","unstructured":"Sziklai I, Komora V, Ribari O (1992) Double-blind study on the effectiveness of a bioflavonoid in the control of tinnitus in otosclerosis. Acta Chir Hung 33(1\u20132):101\u2013107","journal-title":"Acta Chir Hung"},{"issue":"3","key":"2126_CR55","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/019459988509300305","volume":"93","author":"GB Brookes","year":"1985","unstructured":"Brookes GB (1985) Vitamin D deficiency and otosclerosis. Otolaryngol Head Neck Surg 93(3):313\u2013321","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"2126_CR56","first-page":"102","volume":"6","author":"GB Brookes","year":"1985","unstructured":"Brookes GB (1985) Vitamin D deficiency and deafness: 1984 update. Am J Otol 6(1):102\u2013107","journal-title":"Am J Otol"},{"issue":"10","key":"2126_CR57","first-page":"1493","volume":"17","author":"T Michigami","year":"2007","unstructured":"Michigami T (2007) Vitamin D metabolism and action. Clin Calcium 17(10):1493\u20131498","journal-title":"Clin Calcium"},{"issue":"5","key":"2126_CR58","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1017\/S0022215100094330","volume":"97","author":"GB Brookes","year":"1983","unstructured":"Brookes GB (1983) Vitamin D deficiency\u2014a new cause of cochlear deafness. J Laryngol Otol 97(5):405\u2013420","journal-title":"J Laryngol Otol"},{"key":"2126_CR59","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1196\/annals.1398.044","volume":"1109","author":"H Orbach","year":"2007","unstructured":"Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G et al (2007) Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci 1109:385\u2013400","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"2126_CR60","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/ard.2009.120329","volume":"69","author":"H Amital","year":"2010","unstructured":"Amital H, Szekanecz Z, Szucs G, Danko K, Nagy E, Csepany T et al (2010) Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 69(6):1155\u20131157","journal-title":"Ann Rheum Dis"},{"issue":"6286","key":"2126_CR61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/bmj.283.6286.273-a","volume":"283","author":"EB Brookes","year":"1981","unstructured":"Brookes EB, Morrison AW (1981) Vitamin D deficiency and deafness. Br Med J (Clin Res Ed) 283(6286):273\u2013274","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"3","key":"2126_CR62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.autrev.2010.09.018","volume":"10","author":"E Zold","year":"2011","unstructured":"Zold E, Szodoray P, Nakken B, Barath S, Kappelmayer J, Csathy L et al (2011) Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease. Autoimmun Rev 10(3):155\u2013162","journal-title":"Autoimmun Rev"},{"issue":"Suppl 1","key":"2126_CR63","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4158\/EP10281.RA","volume":"17","author":"MD Ruppe","year":"2011","unstructured":"Ruppe MD (2011) Medications that affect calcium. Endocr Pract 17(Suppl 1):26\u201330","journal-title":"Endocr Pract"},{"issue":"10","key":"2126_CR64","doi-asserted-by":"crossref","first-page":"e13305","DOI":"10.1371\/journal.pone.0013305","volume":"5","author":"L Hu","year":"2010","unstructured":"Hu L, Lind T, Sundqvist A, Jacobson A, Melhus H (2010) Retinoic acid increases proliferation of human osteoclast progenitors and inhibits RANKL-stimulated osteoclast differentiation by suppressing RANK. PLoS One 5(10):e13305","journal-title":"PLoS One"},{"issue":"1","key":"2126_CR65","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-2007-996822","volume":"78","author":"W Arnold","year":"1999","unstructured":"Arnold W, Kau R, Schwaiger M (1999) Clinical aspects of the osteolytic (inflammatory) phase of cochlear otosclerosis. Laryngorhinootologie 78(1):20\u201323","journal-title":"Laryngorhinootologie"},{"issue":"8","key":"2126_CR66","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/MAO.0b013e31819fe802","volume":"30","author":"T Karosi","year":"2009","unstructured":"Karosi T, Csomor P, Petko M, Liktor B, Szabo LZ, Pytel J et al (2009) Histopathology of nonotosclerotic stapes fixations. Otol Neurotol 30(8):1058\u20131066","journal-title":"Otol Neurotol"},{"issue":"6","key":"2126_CR67","first-page":"809","volume":"21","author":"H Riechelmann","year":"2000","unstructured":"Riechelmann H, Tholen M, Keck T, Rettinger G (2000) Perioperative glucocorticoid treatment does not influence early post-laser stapedotomy hearing thresholds. Am J Otol 21(6):809\u2013812","journal-title":"Am J Otol"},{"issue":"6","key":"2126_CR68","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000073516","volume":"8","author":"HP Niedermeyer","year":"2003","unstructured":"Niedermeyer HP, Zahneisen G, Luppa P, Busch R, Arnold W (2003) Cortisol levels in the human perilymph after intravenous administration of prednisolone. Audiol Neurootol 8(6):316\u2013321","journal-title":"Audiol Neurootol"},{"issue":"2","key":"2126_CR69","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.amjoto.2004.11.001","volume":"26","author":"I Yilmaz","year":"2005","unstructured":"Yilmaz I, Yilmazer C, Erkan AN, Aslan SG, Ozluoglu LN (2005) Intratympanic dexamethasone injection effects on transient-evoked otoacoustic emission. Am J Otolaryngol 26(2):113\u2013117","journal-title":"Am J Otolaryngol"},{"issue":"9","key":"2126_CR70","doi-asserted-by":"crossref","first-page":"e24285","DOI":"10.1371\/journal.pone.0024285","volume":"6","author":"LF Zerbini","year":"2011","unstructured":"Zerbini LF, Tamura RE, Correa RG, Czibere A, Cordeiro J, Bhasin M et al (2011) Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-kappaB inhibitors in ovarian cancer therapy. PLoS One 6(9):e24285","journal-title":"PLoS One"},{"issue":"3","key":"2126_CR71","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1113\/eph8602135","volume":"86","author":"D Guez","year":"2001","unstructured":"Guez D, Lesclous P, Baroukh B, Saffar JL (2001) Impact of the timing of indomethacin treatment in a model of synchronized bone remodelling in rats. Exp Physiol 86(3):373\u2013379","journal-title":"Exp Physiol"},{"issue":"3","key":"2126_CR72","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/archotol.1991.01870150035002","volume":"117","author":"K Adachi","year":"1991","unstructured":"Adachi K, Chole RA, Yee J (1991) Indomethacin inhibition of middle ear bone resorption. Arch Otolaryngol Head Neck Surg 117(3):267\u2013269","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"6","key":"2126_CR73","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1177\/019459989010300619","volume":"103","author":"CC Huang","year":"1990","unstructured":"Huang CC, Yabe Y, Yan SD (1990) Effects of indomethacin and calcitonin on bone absorption in type II collagen-induced otosclerosis-like lesions in rats. Otolaryngol Head Neck Surg 103(6):1002\u20131008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2126_CR74","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.autrev.2010.07.011","volume":"9","author":"Z Szekanecz","year":"2010","unstructured":"Szekanecz Z, Szanto S, Szabo Z, Vancsa A, Szamosi S, Bodnar N et al (2010) Biologics\u2014beyond the joints. Autoimmun Rev 9:820\u2013824","journal-title":"Autoimmun Rev"},{"issue":"3","key":"2126_CR75","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/rheumatology\/keh483","volume":"44","author":"S Mpofu","year":"2005","unstructured":"Mpofu S, Fatima F, Moots RJ (2005) Anti-TNF-alpha therapies: they are all the same (aren\u2019t they?). Rheumatology (Oxford) 44(3):271\u2013273","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"2126_CR76","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000095897","volume":"11","author":"F Wijk Van","year":"2006","unstructured":"Van Wijk F, Staecker H, Keithley E, Lefebvre PP (2006) Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss. Audiol Neurootol 11(6):357\u2013365","journal-title":"Audiol Neurootol"},{"issue":"3","key":"2126_CR77","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/art.21179","volume":"53","author":"EL Matteson","year":"2005","unstructured":"Matteson EL, Choi HK, Poe DS, Wise C, Lowe VJ, McDonald TJ et al (2005) Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study. Arthritis Rheum 53(3):337\u2013342","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2126_CR78","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/01.mao.0000185082.28598.87","volume":"26","author":"S Cohen","year":"2005","unstructured":"Cohen S, Shoup A, Weisman MH, Harris J (2005) Etanercept treatment for autoimmune inner ear disease: results of a pilot placebo-controlled study. Otol Neurotol 26(5):903\u2013907","journal-title":"Otol Neurotol"},{"issue":"4","key":"2126_CR79","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000320606","volume":"16","author":"S Cohen","year":"2011","unstructured":"Cohen S, Roland P, Shoup A, Lowenstein M, Silverstein H, Kavanaugh A et al (2011) A pilot study of rituximab in immune-mediated inner ear disease. Audiol Neurootol 16(4):214\u2013221","journal-title":"Audiol Neurootol"},{"issue":"2","key":"2126_CR80","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/00498250802590745","volume":"39","author":"Y Miyaji","year":"2009","unstructured":"Miyaji Y, Kurihara A, Kamiyama E, Shiiki T, Kawai K, Okazaki O (2009) Pharmacokinetics and disposition of recombinant human osteoprotegerin (rhOPG) after intravenous administration in female Fischer rats. Xenobiotica 39(2):113\u2013124","journal-title":"Xenobiotica"},{"issue":"4","key":"2126_CR81","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/BOR.0b013e32832ca41c","volume":"21","author":"EM Lewiecki","year":"2009","unstructured":"Lewiecki EM (2009) Denosumab update. Curr Opin Rheumatol 21(4):369\u2013373","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"2126_CR82","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jbmr.212","volume":"26","author":"JA Eisman","year":"2011","unstructured":"Eisman JA, Bone HG, Hosking DJ, McClung MR, Reid IR, Rizzoli R et al (2011) Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect. J Bone Miner Res 26(2):242\u2013251","journal-title":"J Bone Miner Res"},{"key":"2126_CR83","first-page":"93","volume":"65","author":"T Karosi","year":"2007","unstructured":"Karosi T, Konya J, Szabo LZ, Sziklai I (2007) Measles virus prevalence in otosclerotic foci. Adv Otorhinolaryngol 65:93\u2013106","journal-title":"Adv Otorhinolaryngol"},{"key":"2126_CR84","doi-asserted-by":"crossref","unstructured":"McKenna MJ, Mills BG (1990) Ultrastructural and immunohistochemical evidence of measles virus in active otosclerosis. Acta Otolaryngol Suppl 470:130\u2013139 (discussion 139\u2013140)","DOI":"10.3109\/00016488909138367"},{"issue":"5","key":"2126_CR85","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/00016489609137910","volume":"116","author":"W Arnold","year":"1996","unstructured":"Arnold W, Niedermeyer HP, Lehn N, Neubert W, Hofler H (1996) Measles virus in otosclerosis and the specific immune response of the inner ear. Acta Otolaryngol 116(5):705\u2013709","journal-title":"Acta Otolaryngol"},{"issue":"7","key":"2126_CR86","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00405-007-0253-9","volume":"264","author":"W Arnold","year":"2007","unstructured":"Arnold W, Busch R, Arnold A, Ritscher B, Neiss A, Niedermeyer HP (2007) The influence of measles vaccination on the incidence of otosclerosis in Germany. Eur Arch Otorhinolaryngol 264(7):741\u2013748","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2126_CR87","first-page":"17","volume":"65","author":"HP Niedermeyer","year":"2007","unstructured":"Niedermeyer HP, Hausler R, Schwub D, Neuner NT, Busch R, Arnold W (2007) Evidence of increased average age of patients with otosclerosis. Adv Otorhinolaryngol 65:17\u201324","journal-title":"Adv Otorhinolaryngol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-012-2126-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-012-2126-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-012-2126-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T21:07:03Z","timestamp":1562015223000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-012-2126-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,29]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["2126"],"URL":"https:\/\/doi.org\/10.1007\/s00405-012-2126-0","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,29]]}}}